Graybug Vision, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRAY research report →
About the company
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye.
- CEO
- Frederic Guerard
- IPO
- 2020
- Employees
- 8
- HQ
- Redwood City, CA, US
Price Chart
- Market Cap
- $120.98M
- P/E
- -4.23
- P/S
- 0.00
- P/B
- -74.78
- EV/EBITDA
- -8.63
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 4092.98%
- ROIC
- -674.61%
- Revenue
- $0 · 0.00%
- Net Income
- $-29,562,000 · -115.78%
- EPS
- $-1.97 · -61.48%
- Op Income
- $-23,121,000
- FCF YoY
- -0.25%
- 52W High
- $20.30
- 52W Low
- $4.88
- 50D MA
- $8.55
- 200D MA
- $11.51
- Beta
- 1.20
- Avg Volume
- 5.28K
Get TickerSpark's AI analysis on GRAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 11, 23 | WILSON ROBERT N | buy | 506 |
| Nov 7, 23 | Leheny A. Rachel | buy | 2,000 |
| Nov 6, 23 | Roberts Eric W | buy | 2,400 |
| Nov 3, 23 | Roberts Eric W | buy | 11,249 |
| Nov 3, 23 | Roberts Eric W | buy | 3,700 |
| Nov 6, 23 | Leheny A. Rachel | buy | 2,440 |
| Nov 3, 23 | Hebbar Sudarshan | buy | 36,000 |
| Nov 3, 23 | Roberts Eric W | buy | 5,860 |
| Nov 3, 23 | Roberts Eric W | buy | 3,200 |
| Nov 3, 23 | Leheny A. Rachel | buy | 5,000 |
Our GRAY coverage
Recent articles, reports, and earnings notes.
No research on GRAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GRAY report →Similar companies
Peers in the same neighborhood.